Daniel Carleton Gajdusek was an American physician and virologist who won the 1976 Nobel Prize in Physiology or Medicine for demonstrating that kuru, a fatal brain disease found among the Fore people of Papua New Guinea, could be transmitted to laboratory animals. That achievement reshaped scientific understanding of infectious disease and opened the door to an entirely new category of pathogen. Yet Gajdusek’s legacy is permanently fractured: in 1997 he pleaded guilty to child molestation involving a teenage boy, spent a year in prison, and lived the rest of his life in exile. His story sits at an uncomfortable intersection of groundbreaking science and personal criminality, and neither half can be understood without the other.
Early Career and Arrival in Papua New Guinea
Born in 1923 in Yonkers, New York, Gajdusek trained in pediatrics and virology at Harvard and Caltech before spending much of his early career studying infectious diseases in remote parts of the world. He was restless, brilliant, and drawn to problems other researchers avoided. In 1957, while working at the Walter and Eliza Hall Institute in Melbourne, he learned of a mysterious illness killing members of the Fore linguistic group in the Eastern Highlands of what was then the Territory of Papua and New Guinea. The disease was called kuru, a Fore word meaning “to tremble.” Victims developed progressive cerebellar ataxia, uncontrollable tremors, difficulty walking and speaking, and eventually became unable to eat or care for themselves. Death followed within a year of symptom onset. There was no fever, no sign of conventional infection, and no known cause.
Gajdusek traveled to the region and began collecting clinical observations, family histories, blood samples, and brain tissue from deceased patients. He worked alongside anthropologists and the Australian colonial medical service, documenting the disease’s striking demographic pattern: it overwhelmingly affected women and young children of both sexes, while adult men were largely spared. That pattern eventually pointed toward the route of transmission, though it took years and considerable controversy to establish it.
Kuru and Endocannibalism
The Fore practiced mortuary feasting, a form of endocannibalism in which deceased relatives were consumed as part of funerary rites. Women and children were the primary participants; adult men rarely took part, and when they did, they typically received muscle tissue rather than the brain and viscera consumed by women. This practice explained the lopsided demographics of kuru almost perfectly. The infectious agent was concentrated in the brain, and those who handled and ate brain tissue were overwhelmingly women and the children in their care.
Once a person became infected through consuming contaminated tissue, the disease could incubate silently for years or even decades before symptoms appeared. When that person died and was consumed in turn by relatives and guests from other communities, the infection spread outward. Participation in these feasts by relatives from neighboring groups allowed kuru to expand across the entire Fore region over time.1PubMed Central. Cultural factors that affected the spatial and temporal epidemiology of kuru Australian colonial authorities suppressed the practice of endocannibalism beginning in the late 1950s, and kuru incidence began a long, steady decline. But the disease did not vanish overnight. Cases continued to appear for decades in people who had participated in mortuary feasts as children before the ban took effect.
The Transmission Experiments That Won the Nobel
In the early 1960s, most scientists considered kuru a genetic disease. Gajdusek initially entertained that possibility himself, but he became increasingly convinced that the illness behaved like an infection with an extraordinarily long incubation period. The key obstacle was proving it. No bacterium or virus had been found in kuru-affected brains using standard techniques. Gajdusek, working with Clarence Joseph Gibbs Jr. at the National Institutes of Health, decided to attempt direct transmission to primates.
They inoculated chimpanzees with brain tissue suspensions from patients who had died of kuru. After incubation periods ranging from eighteen to twenty-six months, the first three inoculated chimpanzees developed a progressive neurological disorder closely resembling human kuru. Serial transmission from the first affected chimpanzee to two additional animals succeeded, with incubation periods of eleven and twelve months.2PubMed. Experimental transmission of a Kuru-like syndrome to chimpanzees This was the proof the scientific community needed: kuru was transmissible, caused by some kind of infectious agent, and could cross from human tissue into another primate species. The successful transmission, first reported in 1966, was a landmark. It earned Gajdusek the Nobel Prize in Physiology or Medicine in 1976, shared with Baruch Blumberg, who was recognized for unrelated work on the hepatitis B virus.
Subsequent experiments went further, demonstrating that kuru, Creutzfeldt-Jakob disease, and scrapie could all be transmitted to squirrel monkeys through oral consumption of infected tissue alone, without injection. The incubation period in a monkey exposed orally to kuru was about 36 months, compared to 23 to 27 months for Creutzfeldt-Jakob disease and 25 to 32 months for scrapie.3PubMed. Oral transmission of kuru, Creutzfeldt-Jakob disease, and scrapie to nonhuman primates These oral-transmission results reinforced the link between kuru and the mortuary feasting route in humans.
Connecting Kuru to Scrapie, CJD, and the Birth of Prion Science
Gajdusek’s work did not happen in isolation from veterinary science. Scrapie, a fatal neurological disease of sheep, had been known for centuries and had already been shown to be transmissible in the 1930s. When neuropathologists examined kuru brains, the similarities to scrapie were striking: neuronal degeneration, intense proliferation of star-shaped brain cells called astrocytes, and very little of the inflammation you would normally expect from an infection. Particularly eye-catching in kuru were vacuolated neurons, the sponge-like holes in brain tissue that were already the hallmark of scrapie.4PubMed. Neuropathology and the scrapie-kuru connection
Gajdusek grouped kuru with scrapie and Creutzfeldt-Jakob disease under the umbrella of “slow virus infections,” a term that captured the long incubation periods and progressive course. After successfully transmitting kuru to chimpanzees, his laboratory also transmitted Creutzfeldt-Jakob disease to primates, establishing this entire category of human transmissible brain diseases.5PubMed Central. Kuru: memories of the NIH years All of them shared a distinctive neuropathology: spongiform change, neuronal vacuolation, astrocyte overgrowth, and the variable presence of amyloid plaques.6PubMed. Relationship of microglia and scrapie amyloid-immunoreactive plaques in kuru, Creutzfeldt-Jakob disease and Gerstmann-Sträussler syndrome
The “slow virus” label turned out to be wrong in a fascinating way. Despite years of searching, no one could find a nucleic acid genome in the infectious agent. In the 1980s and 1990s, Stanley Prusiner proposed that the infectious particle was a misfolded protein, not a virus at all. He coined the term “prion” for these agents, which appear to be composed exclusively of a misfolded form of a normal brain protein. The misfolded version acts as a template, causing normal copies of the protein to refold into the disease-causing shape.7PubMed Central. Prions Prusiner won his own Nobel Prize in 1997 for this work. What Gajdusek had called a slow virus was actually something entirely new to biology: an infectious protein.
Gajdusek never fully embraced the prion hypothesis. He acknowledged that the agent lacked a conventional genome, but he resisted the idea that a protein alone could be infectious, preferring more cautious language about an unconventional agent. This stubbornness is a recurring theme in Gajdusek’s scientific personality: he was often right about the big picture while clinging to specifics that the field later moved past.
Kuru Plaques and What They Taught Neuropathology
One lasting contribution of kuru research to medicine is the identification of a distinctive type of amyloid plaque in brain tissue. These “kuru plaques” appear as stellate arrangements of amyloid fibers radiating from a dense interwoven center, and they are found in all cases of kuru and in Gerstmann-Sträussler-Scheinker disease, as well as in roughly 10 to 15 percent of sporadic Creutzfeldt-Jakob disease cases.8PubMed. Amyloid plaques in transmissible spongiform encephalopathies (prion diseases) The name “kuru plaque” persists in clinical neuropathology today. A specific subtype of sporadic CJD is even classified by the presence of these plaques, particularly in the cerebellum’s granular layer.9PubMed Central. Defining the phenotypic spectrum of sporadic Creutzfeldt–Jakob disease MV2K: the kuru plaque type Kuru, in other words, gave neuropathologists a diagnostic marker that remains useful for classifying prion diseases half a century later.
Incubation Periods That Stretched for Decades
Perhaps the most remarkable feature of kuru is how long it can hide. Endocannibalism among the Fore effectively ended by 1960. Yet new kuru cases continued to appear for more than 40 years. A clinical study of late-epidemic patients in Papua New Guinea found that all of them had been born well before mortuary practices ceased, and some had estimated incubation periods exceeding 50 years.10PubMed Central. A clinical study of kuru patients with long incubation periods at the end of the epidemic in Papua New Guinea Separate research confirmed that transmission had stopped by 1960 and that patients seen as late as 1995 had incubation periods of at least 35 years.11Communicable Diseases Intelligence. The epidemiology of kuru in the period 1987 to 1995
These findings carry direct implications for other prion diseases. When variant Creutzfeldt-Jakob disease (vCJD) emerged in the United Kingdom in the 1990s, linked to the consumption of beef contaminated with bovine spongiform encephalopathy (BSE, or “mad cow disease”), public health officials looked to kuru for guidance on what to expect. Kuru’s decades-long incubation periods suggested that vCJD cases could continue to appear long after the dietary exposure had ended, making kuru newly relevant on a global scale.12The Lancet. Kuru in the 21st century—an acquisition with very long incubation periods The kuru experience became the principal model for understanding what a human prion epidemic might look like over time.
Genetic Resistance Among the Fore
The kuru epidemic, devastating as it was, left a genetic signature in the surviving Fore population that has fascinated geneticists. Researchers identified a variant in the prion protein gene called G127V that appeared exclusively among people who lived in the region where kuru had been most prevalent. This variant was found in about half the otherwise susceptible women from the area of highest exposure and was completely absent in kuru patients and in populations around the world that had never been exposed to the disease.13PubMed. A novel protective prion protein variant that colocalizes with kuru exposure Family analyses showed that pedigrees carrying the protective variant had significantly lower rates of kuru than matched families without it.
Laboratory studies later confirmed the power of this variant. Mice engineered to carry the G127V change were completely resistant to all prion disease strains tested, making it one of the strongest naturally occurring resistance factors ever documented for any infectious disease.14PubMed Central. A naturally occurring variant of the human prion protein completely prevents prion disease The variant arose and spread under intense natural selection during the kuru epidemic itself, representing a remarkable example of recent human evolution driven by an infectious disease. In genetic terms, the Fore population was evolving in real time under the pressure of an epidemic that killed a substantial fraction of its women in every generation.
The Adopted Children and the Criminal Conviction
Throughout his career, Gajdusek adopted or sponsored more than 50 children from Papua New Guinea, Micronesia, and other Pacific Island communities, bringing them to the United States to live with him and receive Western educations. He framed this as a form of cultural mentorship, and many of the children went on to successful careers. But the arrangement placed vulnerable minors from remote communities in a relationship of total dependency on a single powerful adult, far from their families and cultural support systems.
In 1996, Gajdusek was charged with child molestation after one of his adopted sons, now a young adult, reported sexual abuse that had occurred when the boy was a teenager. Gajdusek pleaded guilty in 1997 to one count of child molestation and was sentenced to twelve months in prison. After his release, he left the United States and spent his remaining years in Europe, primarily in Paris and Amsterdam, never returning. He died in Tromsø, Norway, in 2008 at the age of 85.
The conviction was not an isolated allegation. Gajdusek’s own journals, portions of which were made available to investigators, contained entries that described sexual contact with boys in terms that made his patterns of behavior difficult to dismiss as a single lapse. Some colleagues who had known him for decades expressed shock; others admitted that his unusually intimate domestic arrangements with young boys had long generated private concern within the scientific community. The case raised questions about the extent to which institutional prestige and a Nobel Prize had shielded Gajdusek from scrutiny that would have been applied more quickly to someone less celebrated.
How the Scientific Community Has Handled the Legacy
Gajdusek’s case sits alongside a small number of other instances where major scientific contributors have been convicted of serious crimes, and the scientific community has never developed a consistent framework for handling them. His Nobel Prize was not revoked; the Nobel Foundation has never rescinded a prize for personal conduct. His published research remains in the literature, cited routinely by prion scientists who have no choice but to reference foundational work. The NIH laboratory he ran for decades continued its prion research under other leadership.
Some institutions have quietly distanced themselves. Gajdusek does not feature prominently in NIH public communications about prion research history, and retrospective accounts of kuru science increasingly center the contributions of collaborators like Gibbs, Michael Alpers, and the Fore communities themselves. The Fore people, who were the subjects of intensive research for decades, have their own perspectives on the scientific investigations that descended on their communities during the kuru epidemic. Fieldwork aimed at recording those perspectives has emphasized the importance of obtaining Fore narratives in their own terms, rather than filtering everything through the lens of Western researchers.15Field Methods. Kuru Truths: Obtaining Fore Narratives
The discomfort is genuine and unresolvable in any tidy way. Gajdusek’s transmission experiments were pivotal. They opened the door to the prion concept, informed the global response to mad cow disease, and contributed to the discovery of genetic resistance factors that could matter for future epidemics. None of that changes the fact that he was a convicted child molester who exploited his access to vulnerable children. Both things are true at the same time, and the scientific record has to accommodate both.
What Kuru Research Means for Modern Prion Science
The practical relevance of kuru research extends well beyond a single disease that is now functionally extinct. Prion diseases as a class remain incurable. Chronic wasting disease in deer and elk is spreading across North America, and whether it poses a future risk to humans is an open question. The BSE crisis showed that prion diseases can cross species barriers under the right conditions. Understanding the mechanisms of transmission, the genetics of resistance, and the potential for incubation periods spanning decades all trace directly back to the work that began in Fore country in the late 1950s.
The G127V variant discovered in kuru survivors is being studied as a potential therapeutic lead. If a naturally occurring protein variant can completely block prion replication, it may be possible to design drugs or gene therapies that mimic its protective effect. That line of research is still early, but it would not exist without the kuru epidemic and the genetic data collected from its survivors. Meanwhile, blood-screening policies in the UK and other countries that experienced BSE continue to be shaped by kuru-derived models of how long prion diseases can hide before symptoms emerge. The last case of kuru was reported in the early 2000s, but the science it generated is far from finished.